- Condition: Complicated Skin and Soft Tissue Infection
Interventions: Drug: Ceftaroline fosamil; Drug: Vancomycin; Drug: Aztreonam
Sponsors: AstraZeneca; AstraZeneca; Cerexa, Inc.
Not yet recruiting - verified March 2012 - Condition: Complication of Transplanted Lung
Interventions: Drug: Aztreonam Lysine for Inhalation (AZLI); Procedure: Status Post Lung Transplant
Sponsors: Duke University; Duke University; Gilead Sciences
Not yet recruiting - verified April 2012 - Conditions: Cystic Fibrosis; Pseudomonas Aeruginosa
Intervention: Drug: Aztreonam Lysine for Inhalation (AZLI)
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Infections, Pediatrics
Interventions: Drug: Ceftaroline fosamil; Drug: Vancomycin +/- Aztreonam or Cefazolin +/- Aztreonam; Drug: Cephalexin or Clindamycin
Sponsors: Cerexa, Inc.; Cerexa, Inc.; AstraZeneca
Recruiting - verified May 2012 - Condition: Cystic Fibrosis
Intervention: Drug: Aztreonam Lysine for Inhalation (AZLI)
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified April 2012 - Condition: Bronchiectasis
Interventions: Drug: Aztreonam for Inhalation Solution (AZLI); Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified May 2011 - Condition: Bronchiectasis
Interventions: Drug: Aztreonam for Inhalation Solution (AZLI); Drug: Placebo
Sponsors: Gilead Sciences; Gilead Sciences
Recruiting - verified June 2011
 |
Aztreonam Clinical Trials |
